Clinical cancer prevention
著者
書誌事項
Clinical cancer prevention
(Recent results in cancer research, v. 188)
Springer, c2011
- : hbk
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
"This book is based on presentations by some of the world's leading experts at the Sixth International Conference on Clinical Cancer Prevention, held in St. Gallen, Switzerland, during March 2010."--B.c.
内容説明・目次
内容説明
This book is based on presentations by some of the world's leading experts at the Sixth International Conference on Clinical Cancer Prevention, held in St. Gallen, Switzerland, during March 2010. The main themes are the latest advances in the prevention of breast and prostate cancer and the role of infection in the development of liver and gastric cancer. Special emphasis is given to perspectives on the chemoprevention of breast cancer, as the conference included an international consensus meeting on this subject. New research findings are presented and potentially more effective cancer prevention strategies are discussed, with careful consideration of controversies. The expertise of the contributors encompasses genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention. This book will be of interest to all who wish to learn about the most recent progress in combating the development of cancer.
目次
Allocating cancer directed expenditures - Tensions between prevention, early detection and treatment.- Lessons learned from prevention programs: Different endpoints should be used in secondary and tertiary prevention.- Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: Issues and opportunities.- Targeting polyamines and inflammation for cancer prevention.- Thinking about the role (largely ignored) of heavy metals in cancer prevention: Hexavalent chromium and melanoma as a case in point.- Hepatitis B virus and cancer prevention.- Chemoprevention of hepatocellular carcinoma in chronic hepatitis C.- Nutritional aspects of primary prostate cancer prevention.- Prostate cancer prevention with 5 alpha reductase inhibitors.- Hormone replacement therapy and breast cancer.- Physical activity and breast cancer: Review of the epidemiologic evidence and biologic mechanisms.- Prevention of breast cancer by newer SERMs and the future.- Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
「Nielsen BookData」 より